Our client is a mid-sized global pharmaceutical company headquartered in India, focusing on the development and manufacturing of IP-led niche finished dosage formulations that are sold in 100+ countries. The client was struggling with increasing pharmacovigilance (PV) costs, with their fixed costs high despite no increase in products. They needed to optimize both their resources and processes for better control, as well as reduce their costs. As a result, they were seeking a single partner to perform End-to-End PV Signal activities.
Please complete the form to download the Case Study and learn how we worked with our client to reduce costs, increase efficiency and compliance, and improve Patient Safety.